我們已在上線! 進一步了解
ACGN

Aceragen Inc

已下市

ACGN已於2023年8月21日下市。

 

關於: Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.

員工: 26

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於ACGN的最新新聞文章。

價格圖表採用Lightweight Charts™實作